WEEKLY TOP 5
YOUR WEEKLY UPDATES FROM SHEBA MEDICAL CENTER
‘Hope Without Boundaries’: Sheba Doctors Save Eyesight’s of Children from Afghanistan
Retinoblastoma (Rb), a potentially deadly malignancy, is the most common eye cancer in children. While in high-income countries Rb is practically curable, in many regions across the globe, especially in low- and midd
le-income countries, barriers to healthcare cause survival rates to plummet below 50%. Rb is recognized by the World Health Organization (WHO) as one of the six index cancers of the Global Initiative for Childhood Cancer (GICC), which strives to achieve at least a 60% survival rate by 2030.
Afghanistan, a low-income country in Central Asia under Taliban control since 2021, witnesses nearly 100 new cases of Rb every year, yet lacks established treatment centers for this fatal disease. Many of these children seek medical aid at one of the National Organization for Ophthalmic Rehabilitation (NOOR) centers across the country, operated by the Afghani International Assistance Mission (IAM). However, these facilities lack appropriate treatment modalities for Rb, and therefore, these children are returned home without receiving necessary care.
The Retinoblastoma Silk Road Program was formed through collaboration between colleagues from Sheba Medical Center– Prof. Ido Didi Fabian, Dr. Mattan Arazi and Dr. Jonathan Kfir, Afghani NOOR/IAM, and Pakistani Rb Centers of Excellence in Lahore and Karachi, supported financially and logistically by Sheba Global, the international division at Sheba Medical Center. The program’s main objective is to establish an official referral pathway for Afghani children with suspected Rb to receive specialized treatment at designated centers in Pakistan.
“Through international collaboration, tele-medicine consultation, geographic coordination and charitable contributions, the Retinoblastoma Silk Road Program aims to significantly reduce child mortality rates caused by this fatal cancer. This joint endeavor aligns with WHO (World Health Organization) goals, and aims to become a model referral pathway for other countries, especially in underserved nations and communities,” said Prof. Fabian
Retinoblastoma Silk Road
Doctor On Call: Proper Breastfeeding
Mona Kidon’s Work Generates Global Buzz
Sheba Advances Future of Healthcare
Positive “REACTION” to Sheba Global Conference
More Posts
Sheba Medical Center Join General Catalyst’s Health Assurance Ecosystem to Advance Innovative Medical Solutions
General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.
Revolutionizing Diagnostic Medicine: Sheba Partners with Aidoc for Early Intracerebral Hemorrhages Detection
A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.
Sheba and Vidac Pharma Partner to Overcome the Warburg Effect
CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.
